Style | Citing Format |
---|---|
MLA | Semnani K, et al.. "Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study." Immunity, Inflammation and Disease, vol. 12, no. 5, 2024, pp. -. |
APA | Semnani K, Sohrabi M, Alavijeh PE, Seyedalinaghi S, Esmaeili S, Halabchi F, Alizadeh Z, Salami A, Khaneshan AS (2024). Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study. Immunity, Inflammation and Disease, 12(5), -. |
Chicago | Semnani K, Sohrabi M, Alavijeh PE, Seyedalinaghi S, Esmaeili S, Halabchi F, Alizadeh Z, Salami A, Khaneshan AS. "Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study." Immunity, Inflammation and Disease 12, no. 5 (2024): -. |
Harvard | Semnani K et al. (2024) 'Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study', Immunity, Inflammation and Disease, 12(5), pp. -. |
Vancouver | Semnani K, Sohrabi M, Alavijeh PE, Seyedalinaghi S, Esmaeili S, Halabchi F, et al.. Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study. Immunity, Inflammation and Disease. 2024;12(5):-. |
BibTex | @article{ author = {Semnani K and Sohrabi M and Alavijeh PE and Seyedalinaghi S and Esmaeili S and Halabchi F and Alizadeh Z and Salami A and Khaneshan AS}, title = {Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study}, journal = {Immunity, Inflammation and Disease}, volume = {12}, number = {5}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Semnani K AU - Sohrabi M AU - Alavijeh PE AU - Seyedalinaghi S AU - Esmaeili S AU - Halabchi F AU - Alizadeh Z AU - Salami A AU - Khaneshan AS TI - Prior Covid-19 Infection Among Newly Diagnosed Tuberculosis Patients in a Tertiary Care Center in Tehran: A Case-Control Study JO - Immunity, Inflammation and Disease VL - 12 IS - 5 SP - EP - PY - 2024 ER - |